Brian M. Strem
President and CEO at Kiora Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Kiora Pharmaceuticals Inc., 3 years.
Kiora Pharmaceuticals Inc.
Director · President and CEO
Chief executive roles
Kiora Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Kiora Pharmaceuticals Inc. | Shares withheld for tax | −1,869 | $2.66 | $4,972 |
| Apr 1, 2026 | Kiora Pharmaceuticals Inc. | Shares withheld for tax | −1,906 | $1.95 | $3,717 |
| Mar 6, 2026 | Kiora Pharmaceuticals Inc. | Grant or award | +16,733 | — | — |
| Mar 3, 2026 | Kiora Pharmaceuticals Inc. | Shares withheld for tax | −238 | $2.02 | $481 |
| Apr 1, 2025 | Kiora Pharmaceuticals Inc. | Grant or award | +15,941 | — | — |
| Jul 1, 2024 | Kiora Pharmaceuticals Inc. | Grant or award | +15,629 | — | — |
| Jun 13, 2024 | Kiora Pharmaceuticals Inc. | Open-market purchase | +3,000 | $5.00 | $15,000 |
| Sep 29, 2023 | Kiora Pharmaceuticals Inc. | Grant or award | +75,000 | — | — |
| Mar 3, 2023 | Kiora Pharmaceuticals Inc. | Grant or award | +15,600 | $3.83 | $59,748 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.